Zhengye Biotechnology Holding (ZYBT) Other Non-Current Liabilities (2024)
Zhengye Biotechnology Holding (ZYBT) reported Other Non-Current Liabilities of $20325.5 for Q4 2024.
Zhengye Biotechnology Holding (ZYBT) Other Non-Current Liabilities (2024) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has 1 years of Other Non-Current Liabilities data on file, last reported at $20325.5 in Q4 2024.
- Other Non-Current Liabilities for Q4 2024 came in at $20325.5, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $20325.5 (changed N/A YoY), and the FY2024 annual result was $20000.0, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $20325.5 in Q4 2024 per ZYBT's latest filing.
- Over five years, Other Non-Current Liabilities peaked at $20325.5 in Q4 2024 and troughed at $20325.5 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Zhengye Biotechnology Holding | 5.49 Mn | 6.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 20,325.50 |